I. Banderker

发表

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial

Rachel P. J. Lai, G. Maartens, R. Wilkinson, 2022, medRxiv.

Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]

L. Dodd, G. Maartens, E. Meintjes, 2021, Wellcome open research.